Translating uveal melanoma cytogenetics into clinical care

Archives of Ophthalmology

Volumn 127, Issue 4, 2009, Pages 423-429

  Damato, Bertil ^a   Coupland, Sarah E ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; CONTROLLED STUDY; CYTOGENETICS; ENUCLEATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; METASTASIS; MONOSOMY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHOTOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; UVEA MELANOMA;

BRACHYTHERAPY; CHROMOSOMES, HUMAN, PAIR 3; CYTOGENETIC ANALYSIS; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; MITOTIC INDEX; MONOSOMY; NEOPLASM METASTASIS; NEURAL NETWORKS (COMPUTER); PHOTOCHEMOTHERAPY; RISK ASSESSMENT; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 65249134483     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.40     Document Type: Article

References (24)

1. Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44(11):4651-4659.
2. Damato B. Choroidal melanoma endoresection, dandelions and allegory-based medicine. Br J Ophthalmol. 2008;92(8):1013-1014.
3. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromo- some 8q in a uveal melanoma. Cancer Genet Cytogenet. 1990;45(2):249-253.
4. Sisley K, Rennie IG, Cottam DW, Potter AM, Potter CW, Rees RC. Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer. 1990;2(3):205-209.
5. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347(9010): 1222-1225.
6. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci. 2003;44(3):1008-1011.
7. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83(2):354-359.
8. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res. 1999;59 (13):3032-3037.
9. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114(10):1925-1931.
10. Parrella P, Fazio VM, Gallo AP, Sidransky D, Merbs SL. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res. 2003;63(23):8507-8510.
11. Tschentscher F, Prescher G, Horsman DE, et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res. 2001;61(8):3439-3442.
12. Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology. 2008;115(9):1598-1607.
13. van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn MolPathol. 2005;14(1):9-16.
14. Damato B, DopieralaJ, KlaasenA,et al. Coupland. Multiplexligation- dependentprobe amplification of uveal melanoma: correlation with metastatic death [published online January 31, 2009]. Invest Ophthalmol Vis Sci. doi:10.1167/IOVS.08-3165.
15. Sen J, Groenewald C, Hiscott PS, Smith PA, Damato BE. Transretinal choroidal tumor biopsy with a 25-gauge vitrector. Ophthalmology. 2006;113(6):1028-1031.
16. Young TA, Burgess BL, Rao NP, Glasgow BJ, Straatsma BR. Transscleral fine- needle aspiration biopsy of macular choroidal melanoma. Am J Ophthalmol. 2008; 145(2):297-302.
17. Shields CL, Materin MA, Teixeira L, Mashayekhi A, Ganguly A, Shields JA. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy. Ophthalmology. 2007;114(10):1919-1924.
18. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64(20):7205-7209.
19. Singh AD, Bray J, Borden EC. Uveal malignant melanoma: metastasis. In: Singh AD, Damato BE, Pe'er J, et al, eds. Clinical Ophthalmic Oncology. Philadelphia, PA: Saunders Elsevier; 2007:283-288.
20. Eskelin S, Pyrhonen S, Summanen P, Prause JU, Kivelä T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85(5):1151-1159.
21. Voelter V, Schalenbourg A, Pampallona S, et al. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res. 2008;18 (3):220-224.
22. Damato B. Legacy of the collaborative ocular melanoma study. Arch Ophthalmol. 2007;125(7):966-968.
23. Cook SA, Damato B, Marshall E, Salmon P. Psychological aspects of cytoge-netic testing of uveal melanoma: preliminary findings and directions for future research [published online March 14, 2008]. fye. doi:10.1038/eye.2008.54.
24. Robertson DM. Cytogenetics in the management of uveal melanoma: are we there yet? Arch Ophthalmol. 2008;126(3):409-410.